Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Arrow Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (162)
Cancellation or suspension (56)
Prescription medicine registration (4)
Listed medicine compliance report (1)
Section 14, TGO91 consent (1)

Date

2024 (8)
2023 (32)
2022 (84)
2021 (40)
2020 (11)
2019 (23)
2018 (24)
2017 (2)

Results for "[search-keyword]"

Search

Sponsor content

224 result(s) found, displaying 61 to 70

LEVITAM 1000 levetiracetam 1000 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ZOLPIDEM ARW zolpidem tartrate 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
RISPERIDONE ARW risperidone 4mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
RISPERIDONE ARW risperidone 3mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
RISPERIDONE ARW risperidone 2mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ATENOLOL ARW atenolol 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
RISPERIDONE ARW risperidone 1mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
RISPERIDONE ARW risperidone 0.5mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
MOVALIS meloxicam 15mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
LEVITAM 250 levetiracetam 250 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.